3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
OTHER_GOV
1
Study Type
Observational
1
Sponsor
Cancer Type
Thoracic
1
Conditions
Carcinoma, Non-Small-Cell Lung
78
Lung Neoplasms
44
Carcinoma, Hepatocellular
42
Small Cell Lung Carcinoma
29
Breast Neoplasms
18
Cholangiocarcinoma
17
Urinary Bladder Neoplasms
16
Biliary Tract Neoplasms
15
Liver Neoplasms
13
Neoplasms
12
Neoplasm Metastasis
12
Triple Negative Breast Neoplasms
11
Pancreatic Neoplasms
11
Ovarian Neoplasms
10
Carcinoma
9
Squamous Cell Carcinoma of Head and Neck
8
Endometrial Neoplasms
7
Colorectal Neoplasms
7
Stomach Neoplasms
6
Carcinoma, Transitional Cell
6
Melanoma
5
Gallbladder Neoplasms
5
Esophageal Neoplasms
5
Carcinoma, Renal Cell
5
Adenocarcinoma Of Esophagus
5
Adenocarcinoma
5
Prostatic Neoplasms
4
Non-Muscle Invasive Bladder Neoplasms
4
Neoplasms by Site
4
Mesothelioma
4
Interventions
maltodextrin
2
Resistance Training
2
Exercise
2
pembrolizumab
1
nicotinamide-beta-riboside
1
durvalumab
1
atezolizumab
1
Wearable Electronic Devices
1
Standard of Care
1
Relaxation Therapy
1
Nutrition Therapy
1
Nutrition Assessment
1
Nivolumab
1
Immune Checkpoint Inhibitors
1
Glutamine
1
Gloves, Surgical
1
Geriatric Assessment
1
Creatine
1
Chemotherapy, Adjuvant
1
Carboplatin
1
Caloric Restriction
1
CP protocol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Sarcopenia
×
durvalumab
×
1 year
×
Clear all
NCT07192926
2026-02-20
SARCO-CTI
Ankara Etlik City Hospital
Completed
131 enrolled